BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18678292)

  • 21. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
    J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry.
    Subherwal S; Peterson ED; Chen AY; Roe MT; Washam JB; Gage BF; Bach RG; Bhatt DL; Wiviott SD; Lopes RD; Alexander KP; Wang TY
    Circulation; 2012 Mar; 125(11):1414-23. PubMed ID: 22319105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of elderly adults taking warfarin admitted with prolonged international normalized ratio: a community hospital's experience.
    Bergman M; Ori Y; Blumberger N; Brener ZZ; Salman H
    J Am Geriatr Soc; 2012 Sep; 60(9):1713-7. PubMed ID: 22880717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous warfarin therapy is safe and feasible in catheter ablation of atrial fibrillation.
    Tapanainen JM; Braunschweig F; Schwieler J; Insulander P; Bastani H; Drca N; Kennebäck G; Sadigh B; Jensen-Urstad M
    Scand Cardiovasc J; 2013 Apr; 47(2):109-13. PubMed ID: 23098247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Warfarin management in patients on continuous anticoagulation therapy undergoing total knee replacement.
    Chana R; Salmon L; Waller A; Pinczewski L
    J Bone Joint Surg Br; 2011 Nov; 93(11):1497-502. PubMed ID: 22058301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transvenous lead extraction during uninterrupted warfarin therapy: Feasibility and outcomes.
    Zheng Q; Maytin M; John RM; Killu AM; Epstein LM
    Heart Rhythm; 2018 Dec; 15(12):1777-1781. PubMed ID: 30010055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.
    Limdi NA; Nolin TD; Booth SL; Centi A; Marques MB; Crowley MR; Allon M; Beasley TM
    Am J Kidney Dis; 2015 May; 65(5):701-9. PubMed ID: 25468385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of Uninterrupted Warfarin Therapy in Patients Undergoing Cardiovascular Endovascular Procedures: A Systematic Review and Meta-Analysis.
    Shahi V; Brinjikji W; Murad MH; Asirvatham SJ; Kallmes DF
    Radiology; 2016 Feb; 278(2):383-94. PubMed ID: 26203535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oral diuretics on chronic warfarin therapy: a retrospective study.
    Edwards HD; Webb RD; Conway SE
    Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Uninterrupted Warfarin on Hand and Wrist Surgery.
    Bogunovic L; Gelberman RH; Goldfarb CA; Boyer MI; Calfee RP
    J Hand Surg Am; 2015 Nov; 40(11):2133-40. PubMed ID: 26432767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
    Meijer K; Kim YK; Carter D; Schulman S
    Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of coronary artery bypass surgery during therapeutic oral anticoagulation.
    Airaksinen KE; Biancari F; Karjalainen P; Mikkola R; Kuttila K; Porela P; Laitio T; Lip GY
    Thromb Res; 2011 Nov; 128(5):435-9. PubMed ID: 21683988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implanting cardiac rhythm devices during uninterrupted warfarin therapy: a prospective, single center experience.
    Crosato M; Calzolari V; Franceschini Grisolia E; Daniotti A; Baldessin F; Mantovan R; Olivari Z
    J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):503-6. PubMed ID: 25022924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thrice-weekly warfarin administration: results in 12 hemodialysis patients].
    Poux JM; Dardim K; Nguyen QT; Arnaud G; Rouby MP; Manescu M
    Nephrol Ther; 2013 Nov; 9(6):426-32. PubMed ID: 23830043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for excessive anticoagulation among hospitalized adults receiving warfarin therapy using a pharmacist-managed dosing protocol.
    Berg TM; O'Meara JG; Ou NN; Daniels PR; Moriarty JP; Bergstrahl EJ; Dierkhising RA; Manning DM
    Pharmacotherapy; 2013 Nov; 33(11):1165-74. PubMed ID: 23625787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial.
    Dewilde WJ; Janssen PW; Kelder JC; Verheugt FW; De Smet BJ; Adriaenssens T; Vrolix M; Brueren GB; Van Mieghem C; Cornelis K; Vos J; Breet NJ; ten Berg JM
    EuroIntervention; 2015 Aug; 11(4):381-90. PubMed ID: 24970794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.